摘要 |
<p>The present invention relates to compounds of Formula (I) wherein X, R1, R2, R3, R4 and R5 are as defined herein, which are useful for treating diseases which respond to CXCR2 receptor mediators. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.</p> |
申请人 |
NOVARTIS AG;BAETTIG, URS;D'SOUZA, ANNE-MARIE;HUNT, PETER;PRESS, NEIL JOHN;WATSON, SIMON JAMES |
发明人 |
BAETTIG, URS;D'SOUZA, ANNE-MARIE;HUNT, PETER;PRESS, NEIL JOHN;WATSON, SIMON JAMES |